Abstract: Methods of depositing improved quality silicon nitride (SixNy) films are disclosed. Exemplary methods include exposing a semiconductor substrate in a semiconductor processing chamber to a silicon-containing precursor, to a first plasma produced from a first gas mixture comprising helium (He) and nitrogen (N2), the first gas mixture comprising a ratio of helium:nitrogen in a range of from 20:1 to 1000:1, and exposing the semiconductor substrate to a second plasma produced from a second gas mixture comprising helium (He), nitrogen (N2), and ammonia (NH3).

Abstract: The present application is at least directed to an apparatus on a network including a non-transitory memory including instructions stored thereon for beamforming training. The apparatus also includes a processor, operably coupled to the non-transitory memory, capable of executing the instructions of monitoring a first beamforming training reference signal (BT-RS) and physical broadcast channel (PBCH) of a network node to acquire symbol timing and subframe timing, where a common part of the PBCH includes a first beam ID. The processor is also configured to execute the instructions of transmitting, to the network node, a beam ID feedback with a unique training sequence generated based on the first beam ID to establish a radio resource control (RRC) connection. The processor is further configured to execute the instructions of receiving, from the network node, a second BT-RS to perform beamforming training.

Abstract: Described herein is a multiplex platform that uses ultrasmall nanoparticles (e.g., C dots and C? dots) to graphically differentiate specific nerves (e.g., sensory nerves vs. motor nerves) for nerve transplants and other surgeries. Also described herein is a multiplex platform that uses ultrasmall nanoparticles (e.g., C dots and C? dots) to graphically differentiate between different types of lymph nodes and/or lymphatic pathways, e.g., to safely and effectively perform vascularized lymph node transplantation in the treatment of lymphedema. Also described herein is a multiplex platform that uses ultrasmall nanoparticles (e.g., C dots and C? dots) to graphically differentiate parathyroid tissue.

Abstract: The present disclosure generally provides poly-alkali metal salts of flavanones, dihydrochalcones, and related polyphenolic compounds. In some aspects, the disclosure provides certain compositions that include such poly-alkali metal salts of flavanones, dihydrochalcones, and related polyphenolic compounds, such as compositions that include such poly-alkali metal salts of flavanones, dihydrochalcones, and related polyphenolic compounds and one or more sweeteners. In some other aspects, the disclosure provides methods of reducing the caloric content of a sweetened article, such as a sweetened food or beverage product.

Abstract: An x-ray fluorescence system and method of fabrication are provided which include a titanium x-ray source, a focusing, doubly-curved lithium fluoride (LiF) crystal optic, and a detector. The titanium x-ray source includes a titanium target on which electrons impinge to generate a diverging x-ray beam with a titanium-based characteristic energy, and the focusing, doubly-curved LiF crystal optic monochromates and focuses the diverging x-ray beam from the titanium x-ray source to provide a monochromated and focused x-ray excitation beam directed to impinge on a sample. The crystal optic and the titanium x-ray source operate at a Bragg angle which facilitates polarization within the x-ray fluorescence system. The detector receives fluorescence from the sample induced by the x-ray excitation beam impinging thereon, with the fluorescence is indicative of a concentration of at least one element in the sample.

Abstract: A removal tool is provided. The removal tool includes a wrench apparatus having a body having a handle, wherein a portion of the body is structured to engage a securing member. The removal tool also includes a locking tool assembly and a transfer assembly. The locking tool assembly has a first jaw, a second jaw coupled to the first jaw, and a handle extending from the first jaw, the first and second jaws being structured to engage a conduit. The conduit is coupled to the securing member. The transfer assembly is coupled to the handles of the wrench apparatus and the locking tool assembly in order to transfer a force therebetween, thereby allowing the securing member to be removed from the conduit.

Abstract: Embodiments of the present disclosure relate to a system, a software application, and a method of a lithography process to update one or more of a mask pattern, maskless lithography device parameters, lithography process parameters utilizing a file readable by each of the components of a lithography environment. The file readable by each of the components of a lithography environment stores and shares textual data and facilitates communication between of the components of a lithography environment such that the mask pattern corresponds to a pattern to be written is updated, the maskless lithography device of the lithography environment is calibrated, and process parameters of the lithography process are corrected for accurate writing of the mask pattern on successive substrates.

Abstract: A first apparatus including a processor; and a memory storing computer-executable instructions that when executed by the processor cause the first apparatus to: receive, from a second apparatus, information including Discontinuous Reception (DRX) configurations, wherein one of the DRX configurations is a first active DRX configuration and other DRX configurations are candidate DRX configurations; perform Physical Downlink Control Channel (PDCCH) monitoring in accordance with the first active DRX configuration; monitor signaling from the second apparatus for an indication that is used for adapting the first active DRX configuration; receive from the second apparatus an indication for adapting the first active DRX configuration into a second active DRX configuration; based on the indication for adapting the first active DRX configuration into the second active DRX configuration, adapt the first active DRX configuration into the second active DRX configuration; and perform PDCCH monitoring in accordance with the

Abstract: Composite materials and devices including composite materials are disclosed. Exemplary composite materials include a porous material and ferroelectric nematic liquid crystal within pores of the porous material. The composite materials can be used in a variety of applications, such as capacitors, information storage and processing, actuators, sensors, electro-caloric devices, energy storage and/or conversion devices utilizing piezoelectric effects. The porous material can be a solid, a polymer, glassy, crystalline, amorphous, foam, an aerogel or ceramic.

Abstract: A Sidelink AS group management function is disclosed for a UE to discover group members and organize them into AS layer sub-groups based on the AS layer group context information. A centralized Sidelink AS group management is disclosed that the Sidelink AS Group Manager discovers group members and organizes them into AS layer sub-groups for a UE. A Subgroup formation and configuration procedure is disclosed that SL AS Group Manager organizes the ULG into AS layer sub-groups, configures UE-to-UE relays for each UE in the ULG and sends the AS group management information to the UE. A distributed Sidelink AS group management method is disclosed that each UE discovers its group members and organizes the ULG into AS layer sub-groups. New Layer 2 structures and procedures are disclosed to enhance bearer management for Sidelink groupcast communications.

Abstract: An electronic device that is configured to schedule transmission of data to at least one other electronic device via sidelink resources in a wireless communication network; identify that the scheduled transmission of the data is preempted by another transmission occurring within at least a part of the sidelink resources; and control transmission of the data to at least one other electronic device based on the identifying.

Abstract: The present disclosure relates to heterobifunctional molecules, referred to as cytotoxicity targeting chimeras (CyTaCs) or antibody recruiting molecules (ARMs) that are able to simultaneously bind a target cell-surface protein as well as an exogenous antibody protein. The present disclosure also relates to agents capable of binding to a receptor on a surface of a pathogenic cell and inducing the depletion of the pathogenic cell in a subject for use in the treatment of cancer, inflammatory diseases, autoimmune diseases, viral infection, or bacterial infection.

Abstract: The present application is at least directed to an apparatus on a network including a non-transitory memory including instructions stored thereon for beamforming training. The apparatus also includes a processor, operably coupled to the non-transitory memory, capable of executing the instructions of monitoring a first beamforming training reference signal (BT-RS) and physical broadcast channel (PBCH) of a network node to acquire symbol timing and subframe timing, where a common part of the PBCH includes a first beam ID. The processor is also configured to execute the instructions of transmitting, to the network node, a beam ID feedback with a unique training sequence generated based on the first beam ID to establish a radio resource control (RRC) connection The processor is further configured to execute the instructions of receiving, from the network node, a second BT-RS to perform beamforming training.

Abstract: A discoverer user equipment sends a discovery announcement to a discoveree user equipment via a sidelink service. The announcement includes criteria for a service sought by discoverer. The discoveree assesses the announcement and may respond to the discoverer. The discovery announcement may be a target search discovery announcement or a self-advertisement discovery announcement, and may be unicast, groupcast, or broadcast. The discoverer and discoveree may perform synchronization in support of V2X sidelink communication and may collect driving information pertaining to vehicles associated with the discoverer and discoveree, respectively, such as driving intention, positioning, and environment information. The discoverer may request an authorization for the discovery announcement, and the request may include the driving information.

Abstract: Certain aspects of the present disclosure provide techniques for wireless communication. The techniques include a method wireless communication by a user equipment including receiving a first physical downlink control channel (PDCCH) from a first transmission reception point (TRP) and a second PDCCH from a second TRP, wherein the first PDCCH and the second PDCCH include the same downlink control information (DCI), selecting a physical uplink control channel (PUCCH) resource for transmitting hybrid automatic repeated request acknowledgment (HARQ-ACK) feedback based on one of the first PDCCH or the second PDCCH, and transmitting a PUCCH that includes the HARQ-ACK feedback using the selected PUCCH resource.

Abstract: Methods and apparatuses are described herein for multi-subscriber identification module (SIM) connected mode operation. In one embodiment, a wireless communications device may receive, from an access stratum interface, a request access to the receiver chain during a receiving opportunity. The wireless communications device may determine that the receiver chain is available during the receiving opportunity. The wireless communications device may send a response indicating access is granted to cause the access stratum interface to receive a downlink transmission during the receiving opportunity. The wireless communications device may receive, from the access stratum interface, a second request for a transmitter chain during a transmitting opportunity. The wireless communications device may determine that the transmitter chain is available during the transmitting opportunity.

Abstract: Oral care compositions and methods for treating, preventing, or inhibiting dry mouth and/or inflammation of the oral cavity or a surface thereof are disclosed. Oral care compositions for improving oral care by treating, preventing, or otherwise inhibiting discomfort, irritation, or gum pain of the oral cavity are also disclosed. The oral care composition may include an orally acceptable vehicle, hyaluronic acid, and one or more benefit agents. The method for treating, preventing, or inhibiting dry mouth and/or inflammation of the oral cavity or a surface thereof may include contacting the oral cavity or the surface thereof with the oral care compositions.

Abstract: An apparatus for testing cardiac devices comprises an inflow and an outflow chamber, a mount for supporting a prosthetic valve, and a fluid driving device operable to vary a pressure differential of a fluid between the inflow chamber and the outflow chamber in repeating cycles. The apparatus can comprise a bypass valve to modulate pressure characteristics across the prosthetic valve, reservoirs to maintain a pressure inside the apparatus, and compliance elements to modulate pressure characteristics in the apparatus. Methods for operating the apparatus include controlling the bypass valve to control testing characteristics across the prosthetic device, and methods for monitoring the pressure inside of the apparatus.

Abstract: Structured surfaces are described. In one embodiment, the structured surface comprises a plurality of structures having complement cumulative slope magnitude distribution (Fcc) such that at least 30, 40, 50, 60, 70, 80 or 90% of structures have a slope greater than 10 degrees; and less than 80% of the structures have a slope greater than 35 degrees. In other embodiments, the structures comprise peaks and valleys defined by a Cartesian coordinate system such that the peaks and valleys have a width and length in the x-y plane and a height in the z-direction and at least a portion of the peaks and/or valleys vary in height in the y direction and/or the x-direction by at least 10% of the average height. Articles and methods are also described.

Abstract: Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor nilotinib. The pharmaceutical compositions may be used in methods of treating a proliferative disorder such as cancer. In some embodiments, the pharmaceutical compositions can be administered without regard to food consumption. In other embodiments, the pharmaceutical compositions can be administered at a significantly lower dose as compared to a commercially available immediate-release nilotinib formulation, while providing a comparable therapeutic effect.